Search by...
-
4DecPortolano Cavallo appoints Pablo Fernando Ambrosy Carrera Chief Digital and Innovation OfficerPablo Fernando Ambrosy Carrera joining the team is another sign of the firm’s commitment to digital innovation
-
17AprPortolano Cavallo announces the appointment of Alessandro Tanno as partnerWith Alessandro Tanno's appointment, the number of partners rises to 21
-
6MarInfluencer del farmaco: più attenzione su profili e diffusione di contenuti alla luce delle nuove linee guida AGCOMIl fenomeno degli influencer o testimonial si sta diffondendo sempre di più anche nel mondo pharma, tanto che è stato recentemente coniato il termine di “Pharma Influencer” per indicare un professionista del settore farmaceutico che utilizza i social media e gli strumenti di comunicazione digitali per condividere contenuti relativi alla salute.
-
-
23OctThe digital caregiver: Insights from the 4th AFI Patient DayCon il termine caregiver si intende una persona che presta assistenza quotidiana a chi non è autosufficiente. Può trattarsi, a seconda dei casi, di un familiare del paziente o di una persona retribuita (il/la cosiddetto/a badante).
-
-
28SepSunshine Act: Draft Decree for the Sanità Trasparente electronic register publishedNow available the draft decree and technical specifications envisaged by the Sunshine Act, establishing the structure and technical characteristics of the “Sanità Trasparente” electronic register, and the modalities for manufacturing companies to transmit notifications.
-
-
15SepAI and machine learning in the medicine lifecycle: EMA publishes first draft of reflection paperThe first draft of EMA’s “Reflection paper” contains the authority’s latest considerations on the application of AI and machine learning methods in each phase of the medicinal product lifecycle.
-
-
27JulWhistleblowing Decree: Key points for the pharmaceutical sectorLarge multinational companies are being called to assess the compatibility of existing reporting channels with the requirements of the new regulation published on March 15, 2023 on the Official Journal of the Italian Republic, implementing the EU Directive 2019/1937 on whistleblowing.
-
-
10JulThe AI Act: What will the impact be on the medical device industry?The European Parliament approved the “AI Act” (June 14, 2023), a proposal for a regulation providing a uniform legal framework for the use of artificial intelligence in the EU.
-
-
28JunDigital Therapeutics: EFPIA recommendations for access to digital therapies in the EUThe European Federation of Pharmaceutical Manufacturers & Associations ("EFPIA") published a report on Improving access to digital therapeutics in Europe, aiming to promote a structured approach to the regulation of digital therapeutics ("DTx") on the European market.
-
-
14JunNon-promotional communication: Boost for digital from the Farmindustria Code?The recent amendments to the Farmindustria Code on non-promotional drug interactions may boost pharmaceutical companies’ communication via digital and other channels.
-
